This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing new treatments for ALS with members of The ALS Association
Ticker(s): AMLX, IONSWho's the expert?
Institution: The ALS Association The ALS Association
- Chief Mission Officer, The ALS Association
- Over two decades of experience as a public health expert to the fight against ALS; has led The ALS Association’s mission programs – research, care services, and advocacy – since 2018.
- Prior to joining the Association, Neil served in the National Institutes of Health (NIH) Office of the Director, where he supported NIH governance and helped make NIH research more open and less burdensome.
- Managed the world’s largest policy to make biomedical research papers publicly accessible and co-chaired the White House taskforce that led to the requirement that all federal science agencies adopt similar policies. He also spent a year on detail to the US Senate Special Committee on Aging, raising awareness about quality issues in long-term health care, particularly around Alzheimer’s care and pharmaceuticals.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
